BIO-RAD LABORATORIES, INC. Asset at Fair Value, Changes in Fair Value Resulting from Changes in Assumptions
BIO-RAD LABORATORIES, INC. (BIO.B) reported Asset at Fair Value, Changes in Fair Value Resulting from Changes in Assumptions of $13.20 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes
us-gaap:AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions · last filed 2026-08-04
- BIO-RAD LABORATORIES, INC. asset at fair value, changes in fair value resulting from changes in assumptions for the quarter ending 2026-06-30 was $13.20M.
- BIO-RAD LABORATORIES, INC. asset at fair value, changes in fair value resulting from changes in assumptions for the quarter ending 2026-03-31 was -$3.80M, a 163.33% decline year-over-year.
- BIO-RAD LABORATORIES, INC. asset at fair value, changes in fair value resulting from changes in assumptions for the quarter ending 2025-12-31 was -$25.10M.
- BIO-RAD LABORATORIES, INC. asset at fair value, changes in fair value resulting from changes in assumptions for the quarter ending 2025-09-30 was $6.20M, a 65.75% decline year-over-year.
- BIO-RAD LABORATORIES, INC. asset at fair value, changes in fair value resulting from changes in assumptions for fiscal 2025 was -$16.10M.
- BIO-RAD LABORATORIES, INC. asset at fair value, changes in fair value resulting from changes in assumptions for fiscal 2024 was -$38.40M.
- BIO-RAD LABORATORIES, INC. asset at fair value, changes in fair value resulting from changes in assumptions for fiscal 2023 was -$24.50M, a 195.70% decline from fiscal 2022.
- BIO-RAD LABORATORIES, INC. asset at fair value, changes in fair value resulting from changes in assumptions for fiscal 2022 was $25.60M.
| Period end | Asset at Fair Value, Changes in Fair Value Resulting from Changes in Assumptions 3 month | Asset at Fair Value, Changes in Fair Value Resulting from Changes in Assumptions 6 month | Asset at Fair Value, Changes in Fair Value Resulting from Changes in Assumptions 9 month | Asset at Fair Value, Changes in Fair Value Resulting from Changes in Assumptions 12 month |
|---|---|---|---|---|
| 2026-06-30 | $13.20M 10-Q · filed 2026-08-04 | $9.40M 10-Q · filed 2026-08-04 | -$15.70M derived: sum of 3 quarters · filed 2026-08-04 | -$9.50M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | -$3.80M 10-Q · filed 2026-04-30 | -$28.90M derived: sum of 2 quarters · filed 2026-04-30 | -$22.70M derived: sum of 3 quarters · filed 2026-04-30 | -$25.90M derived: sum of 4 quarters · filed 2026-04-30 |
| 2025-12-31 | -$25.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$18.90M derived: sum of 2 quarters · filed 2026-02-13 | -$22.10M derived: sum of 3 quarters · filed 2026-02-13 | -$16.10M 10-K · filed 2026-02-13 |
| 2025-09-30 | $6.20M 10-Q · filed 2025-10-29 | $3.00M derived: sum of 2 quarters · filed 2025-10-29 | $9.00M 10-Q · filed 2025-10-29 | -$62.50M derived: sum of 4 quarters · filed 2025-10-29 |
| 2025-06-30 | -$3.20M 10-Q · filed 2025-07-31 | $2.80M 10-Q · filed 2025-07-31 | -$68.70M derived: sum of 3 quarters · filed 2025-07-31 | -$50.60M derived: sum of 4 quarters · filed 2025-07-31 |
| 2025-03-31 | $6.00M 10-Q · filed 2025-05-01 | -$65.50M derived: sum of 2 quarters · filed 2025-05-01 | -$47.40M derived: sum of 3 quarters · filed 2025-05-01 | -$41.20M derived: sum of 4 quarters · filed 2025-05-01 |
| 2024-12-31 | -$71.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | -$53.40M derived: sum of 2 quarters · filed 2025-02-14 | -$47.20M derived: sum of 3 quarters · filed 2025-02-14 | -$38.40M 10-K · filed 2025-02-14 |
| 2024-09-30 | $18.10M 10-Q · filed 2024-10-31 | $24.30M derived: sum of 2 quarters · filed 2024-10-31 | $33.10M 10-Q · filed 2024-10-31 | $9.00M derived: sum of 4 quarters · filed 2024-10-31 |
| 2024-06-30 | $6.20M 10-Q · filed 2024-08-02 | $15.00M 10-Q · filed 2024-08-02 | -$9.10M derived: sum of 3 quarters · filed 2024-08-02 | -$19.90M derived: sum of 4 quarters · filed 2024-08-02 |
| 2024-03-31 | $8.80M 10-Q · filed 2024-05-08 | -$15.30M derived: sum of 2 quarters · filed 2024-05-08 | -$26.10M derived: sum of 3 quarters · filed 2024-05-08 | -$23.70M derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-12-31 | -$24.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | -$34.90M derived: sum of 2 quarters · filed 2024-02-16 | -$32.50M derived: sum of 3 quarters · filed 2024-02-16 | -$24.50M 10-K · filed 2024-02-16 |
| 2023-09-30 | -$10.80M 10-Q · filed 2023-10-27 | -$8.40M derived: sum of 2 quarters · filed 2023-10-27 | -$400.00K 10-Q · filed 2023-10-27 | $89.00M derived: sum of 4 quarters · filed 2023-10-27 |
| 2023-06-30 | $2.40M 10-Q · filed 2023-08-04 | $10.40M 10-Q · filed 2023-08-04 | $99.80M derived: sum of 3 quarters · filed 2023-08-04 | $79.80M derived: sum of 4 quarters · filed 2023-08-04 |
| 2023-03-31 | $8.00M 10-Q · filed 2023-05-05 | $97.40M derived: sum of 2 quarters · filed 2023-05-05 | $77.40M derived: sum of 3 quarters · filed 2023-05-05 | |
| 2022-12-31 | $89.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-17 | $69.40M derived: sum of 2 quarters · filed 2023-02-17 | $25.60M 10-K · filed 2023-02-17 | |
| 2022-09-30 | -$20.00M 10-Q · filed 2022-10-28 | -$63.80M 10-Q · filed 2022-10-28 | ||
| 2022-06-30 | $43.70M 10-Q · filed 2022-07-29 |